Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

October 2025

Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years old

Front Med 2025:12;1538170 Doi: 10.3389/fmed.2025.1538170

Fautrel B,

Saraux A,

Idier I,

Combe B

This large French nationwide study by Fautrel et al. provided reassuring results for patients, who initiated tocilizumab (TCZ), aged at least 75 years compared to younger patients. Authors compared patient characteristics, tolerance of RA treatments, and long-term management with TCZ in patients with RA over and under 75 years of age.

Keywords:

August 2025

Efficacy, safety, and drug survival during the first year of biologic therapy for psoriasis in elderly versus younger patients

International Journal of Dermatology 2025;64:1401–1408 Doi: 10.1111/ijd.17814

Sobotkova T,

Hugo J,

Salavec M,

Kojanova M,

Tichy M,

Necas M,

Balaz M,

This study by Sobotkova et al. confirmed the similar efficacy and overall safety of biological treatment for psoriasis in older and younger adult patients. Authors compared a large cohort of older adults during the first year of biological treatment for psoriasis to younger adult patients with similar characteristics to advance knowledge about the biologic treatment of psoriasis in older patients.